Please login to the form below

Not currently logged in
Email:
Password:

Theravance hires BMS veteran Pasqualone

He joins as senior VP, operations

Theravance has named Frank Pasqualone as senior VP, operations.

Pasqualone joins the US-based biopharma from Bristol-Myers Squibb (BMS) where he most recently served as president of the intercontinental region, including Latin America, the Middle East and Africa.

He spent 25 years at BMS, where his roles included present of southern Europe and head of the company's US oncology/virology business. He also led diabetes marketing in the US at one stage.

Pasqualone joins Theravance as the company at a crucial time as its development deals with GlaxoSmithKline bears fruit with US approval of respiratory treatment Anoro Ellipta.

This followed the approval last year of Theravance's antibiotic Vibativ (telavancin) to treat a hospital-acquired lung infection.

Since then, the company has been strengthening its senior business team, a process that has included the appointment of Jeff Jonker as senior VP, corporate and business development.

27th January 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...